Consonance-Hfw Acq Corp (SRZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | SRZN | ENLV | NNVC | ||
Company | Consonance-Hfw Acq Corp | Enlivex Therapeutics Ltd | Nanoviricides Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE Arca | ||
Open | 8.53 | 1.3900 | 2.17 | ||
High | 8.90 | 1.4126 | 2.35 | ||
Low | 8.53 | 1.2300 | 2.16 | ||
Last | 8.57 | 1.3600 | 2.24 | ||
Change | +0.04 | -0.0300 | +0.04 | ||
% Change | +0.47% | -2.16% | +1.82% | ||
Volume | 3,100 | 83,200 | 162,100 | ||
20-Day Average Volume | 7,350 | 39,640 | 308,005 | ||
Previous Close | 8.53 | 1.3900 | 2.20 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.53 | 1.3868 | 1.97 | ||
20-Day Raw Stochastic | 19.00% | 52.00% | 65.56% | ||
20-Day Relative Strength | 40.35% | 44.83% | 54.14% | ||
Weighted Alpha | -13.36 | -42.23 | +37.02 | ||
Today's Opinion | 72% Sell | 100% Sell | 88% Buy | ||
Previous Opinion | 56% Sell | 88% Sell | 88% Buy | ||
Last Month's Opinion | 24% Buy | 88% Sell | 56% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -4.78% since 07/19/24 | +0.37% since 07/19/24 | +5.66% since 07/19/24 | ||
Low | 8.00 on 07/23/24 | 1.2300 on 07/26/24 | 2.16 on 07/26/24 | ||
High | 9.10 on 07/22/24 | 1.4600 on 07/23/24 | 2.55 on 07/24/24 | ||
1-Month | |||||
%Chg | -18.84% since 06/26/24 | -0.73% since 06/26/24 | +23.08% since 06/26/24 | ||
Low | 8.00 on 07/23/24 | 1.2300 on 07/26/24 | 1.65 on 06/28/24 | ||
High | 11.00 on 07/05/24 | 1.5200 on 06/27/24 | 2.55 on 07/24/24 | ||
3-Month | |||||
%Chg | -4.56% since 04/26/24 | -5.56% since 04/26/24 | +103.64% since 04/26/24 | ||
Low | 8.00 on 07/23/24 | 1.1800 on 06/07/24 | 1.10 on 05/03/24 | ||
High | 11.99 on 06/03/24 | 1.8400 on 04/29/24 | 3.59 on 06/10/24 | ||
6-Month | |||||
%Chg | +12.76% since 01/26/24 | -50.90% since 01/26/24 | +109.35% since 01/26/24 | ||
Low | 7.27 on 01/29/24 | 1.1500 on 04/15/24 | 1.03 on 04/25/24 | ||
High | 16.19 on 03/28/24 | 4.5900 on 04/03/24 | 3.59 on 06/10/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 27,414 | 28,386 | 26,463 | ||
Shares Outstanding, K | 3,199 | 20,872 | 11,814 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -43,040,000 | -29,070,000 | -8,590,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -8,830,000 | -4,140,000 | -1,850,000 | ||
60-Month Beta | 0.89 | 0.98 | 0.97 | ||
Per-Share Information | |||||
Most Recent Earnings | -4.24 on 05/08/24 | -0.22 on 06/14/24 | -0.16 on 05/15/24 | ||
Latest Earnings Date | 08/14/24 | 09/06/24 | 05/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |